Thrombotic Effects of Yellowstripe Scad
The Thrombotic Effects of Yellowstripe Scad (YSS) Compared to Salmon Among Healthy Overweight Subjects: A Randomized Cross Over Trial
3 other identifiers
interventional
50
0 countries
N/A
Brief Summary
The study aimed to determine the thrombotic effects of YSS compared with salmon among healthy overweight subjects. It hypothesized that YSS may result significant, favorable thrombotic effects and the effects may be similar with salmon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 9, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 9, 2017
CompletedFirst Submitted
Initial submission to the registry
May 30, 2017
CompletedFirst Posted
Study publicly available on registry
August 16, 2017
CompletedAugust 16, 2017
August 1, 2017
7 months
May 30, 2017
August 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in hemostatic status assessed by immunoassay method
Hemostatic markers including vWF-A2 and CD62b (p-selectin) in pg/mL are evaluated.
8 weeks
Secondary Outcomes (5)
Changes in lipid and glucose profiles analysed by medical diagnostic laboratory
8 weeks
Changes in liver enzymes analysed by medical diagnostic laboratory
8 weeks
Changes in renal function analysed by medical diagnostic laboratory
8 weeks
Changes in body mass index (BMI)
8 weeks
Changes in blood pressure
8 weeks
Study Arms (2)
YSS/salmon group
EXPERIMENTALYSS followed by salmon
Salmon/YSS group
EXPERIMENTALSalmon followed by YSS
Interventions
Eligibility Criteria
You may qualify if:
- Malaysian
- Overweight participants (BMI 23-27.4 kg/m2)
You may not qualify if:
- Regular use of fish oil supplements during the last one month
- Regular consumption of fish twice or more per week
- Vegetarian who excluded all meat, fish, and poultry from their diet
- Diagnosed with cardiovascular disease, haemostasis disorder, inflammatory disease, diabetes mellitus, hypertension, or other significant medical history that may prohibits the participation
- Receiving warfarin or aspirin treatment, or medication to lower serum lipids, blood pressure, and inflammation
- Women who are menopause, pregnant or lactating
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Su Peng Loh, PhD
Universiti Putra Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 30, 2017
First Posted
August 16, 2017
Study Start
October 1, 2016
Primary Completion
May 9, 2017
Study Completion
May 9, 2017
Last Updated
August 16, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share